Three phases of increasing complexity in estimating vaccine protection
Int J Epidemiol
.
2023 Oct 5;52(5):1299-1302.
doi: 10.1093/ije/dyad073.
Authors
Ofra Amir
1
,
Yair Goldberg
1
,
Micha Mandel
2
,
Yinon M Bar-On
3
,
Laurence S Freedman
4
,
Omri Bodenheimer
5
,
Amit Huppert
4
6
,
Ron Milo
3
Affiliations
1
Faculty of Data and Decision Sciences, Technion-Israel Institute of Technology, Haifa, Israel.
2
Statistics and Data Science, Hebrew University of Jerusalem, Jerusalem, Israel.
3
Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel.
4
Bio-Statistical and Bio-Mathematical Unit, Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Ramat Gan, Israel.
5
Israel Ministry of Health, Jerusalem, Israel.
6
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
PMID:
37244650
DOI:
10.1093/ije/dyad073
No abstract available
MeSH terms
Communicable Disease Control*
Humans
Vaccination*
Vaccines*
Substances
Vaccines